Submitted by Anonymous (not verified) on 7 May 2026 - 15:00
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 15, Status: Authorised